Skip to main content

MMRF, Broad Institute Join in Myeloma Tumor Study

NEW YORK (GenomeWeb News) – The Multiple Myeloma Research Foundation will collaborate with the Broad Institute of MIT and Harvard to study the genetics underlying multiple myeloma tumors.

MMRF will provide both patient samples for analysis and funding for the project, which will involve sequencing the whole genomes of the myeloma tumors. MMRF said that it will make all of the data from the collaboration publicly available.

MMRF CEO Kathy Giusti said in a statement that the foundation launched a collaboration three years ago with the Broad and with the Translational Genomics Research Institute called the Multiple Myeloma Genomics Initiative.

The information from the research will be used to add to the data currently catalogued in public resources on cancer biology, such as the Cancer Genome Atlas project.

"The few cancer genomes sequenced to date have been informative, but we need many more to transform cancer research and ultimately cancer therapy," Co-director of the Broad's Genome Sequencing and Analysis Program, Stacey Gabriel, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.